Table 1.

Demographics of the participants

Variables	HIV-	PLWH	p-value
Age (years) (SD)	59.7 (8.7)	57.8 (6.9)	0.09
Education (years) (SD)	14.1 (2.3)	13.5 (2.6)	0.14
Sex, n (% Male)	28 (47%)	117 (80%)	<.001
Race, n (% AAa)	41 (68%)	84 (58%)	0.15
% Employed	53%	31%	0.002
BDI-IIb	5.6 (5.8)	8.5 (7.1)	0.01
Clinical values
Current CD4, Median (IQRc)	N/A	534 (375, 746)	N/A
Nadir CD4, Median (IQR)	N/A	105 (20, 284)	N/A
Undetectable viral load N (%)	N/A	127 (87%)	N/A
Hepatitis C co-infection N (%)	N/A	17 (12%)	N/A
Duration of infection (months), Median (IQR)	N/A	220 (144, 301)	N/A
Months on cART, Median (IQR)	N/A	187 (90, 240)	N/A
Total daily pills (SD)	5.1 (5.7)	8.9 (5.4)	<0.001
MMT-Rd score (SD)	7.0 (2.5)	5.4 (3.1)	<0.001
Self-reported difficulty managing medications (% yes)	17%	21%	0.50

^aAA=African American;

^bBDI-II=Beck Depression Inventory II;

^cIQR=interquartile range;

^d=MMT-R= Medication Management Test-Revised, SD= standard deviation of the participants